By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel agrees that SPGM and SCHE serve different purposes in a portfolio and should not be compared based on expense ratios alone. They highlight significant risks in both funds, including concentration risk in SCHE and currency risk in SPGM.
Risk: Concentration risk in SCHE (16.3% in TSMC) and currency risk in SPGM (62% U.S. tilt)
Opportunity: Potential for SCHE to shine in a new growth regime if EM cycles outperform
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The Schwab Emerging Markets Equity ETF offers a lower expense ratio and higher dividend yield than the global State Street fund.
The State Street SPDR Portfolio MSCI Global Stock Market ETF provides broader diversification across developed and emerging markets.
The State Street SPDR Portfolio MSCI Global Stock Market ETF has delivered higher total returns over the last five years with a lower maximum drawdown.
The State Street SPDR Portfolio MSCI Global Stock Market ETF (NYSEMKT:SPGM) offers all-in-one exposure to developed and emerging markets, while the Schwab Emerging Markets Equity ETF (NYSEMKT:SCHE) focuses exclusively on developing economies.
Investors seeking broad international exposure often decide between a total-world approach and a targeted regional tilt. While SPGM covers the entire global equity landscape including the U.S., SCHE limits its scope to emerging markets. This analysis examines how these distinct geographic mandates influence costs, risk profiles, and historical performance.
| Metric | SPGM | SCHE | |---|---|---| | Issuer | SPDR | Schwab | | Expense ratio | 0.09% | 0.07% | | 1-yr return (as of May 11, 2026) | 29.58% | 24.89% | | Dividend yield | 1.70% | 2.60% | | Beta | 0.92 | 0.87 | | AUM | $1.6 billion | $12.8 billion |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
The Schwab fund is slightly more affordable, featuring a 0.07% expense ratio compared to 0.09% for the State Street fund. It also offers a significantly higher distribution, with a trailing-12-month dividend yield of 2.60% compared to 1.70% for the global ETF.
| Metric | SPGM | SCHE | |---|---|---| | Max drawdown (5 yr) | (25.90%) | (33.80%) | | Growth of $1,000 over 5 years (total return) | $1,775 | $1,373 |
The Schwab Emerging Markets Equity ETF seeks to track the total return of the FTSE Emerging Index, holding 2,211 securities across the market cap spectrum. Its largest positions include Taiwan Semiconductor Manufacturing at 16.31%, Tencent at 3.44%, and Alibaba Group at 2.94%. Launched in 2010, the fund allocates 27% to technology and 22% to financial services. It paid $0.94 per share over the trailing 12 months.
The State Street SPDR Portfolio MSCI Global Stock Market ETF provides a wider net via the MSCI ACWI IMI Index, encompassing 2,949 holdings. Its top positions include Nvidia at 4.37%, Apple at 3.54%, and Microsoft at 2.74%. Launched in 2012, it is part of a low-cost suite designed for core diversification. The fund tilts 25% toward technology and 17% toward financial services, with a trailing-12-month dividend of $1.45 per share.
For more guidance on ETF investing, check out the full guide at this link.
For those seeking to invest beyond solely domestic stocks, the Schwab Emerging Markets Equity ETF (SCHE) and State Street SPDR Portfolio MSCI Global Stock Market ETF (SPGM) provide this. Choosing between these funds depends on a few key factors.
SCHE targets only emerging markets as a means of delivering outsized returns, since these are fast-growing economies. Income-focused investors may find its far higher dividend yield appealing, and it’s less expensive as well.
However, as its top holdings illustrate, it has a substantial stake in Chinese companies, which comprise 31% of the portfolio. While Chinese stocks can perform well, the political climate can shift quickly, and cause the fund’s performance to falter, as illustrated in its higher max drawdown. In addition, one stock, Taiwan Semiconductor Manufacturing, represents a hefty 16% of the ETF’s holdings, meaning a lot rides on this company.
In contrast, SPGM is designed to be a foundational component of a portfolio, since it delivers exposure to equities around the world, including the U.S. In fact, the U.S. comprises 62% of this ETF’s holdings.
For investors who want a more international-focused fund, SPGM isn’t that. But it provides exposure to a range of developed and emerging economies, making it a great building block for those who are getting started in investing.
Before you buy stock in Schwab Strategic Trust - Schwab Emerging Markets Equity ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Schwab Strategic Trust - Schwab Emerging Markets Equity ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $469,293! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,332!
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 17, 2026. *
Robert Izquierdo has positions in Alibaba Group, Apple, Microsoft, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has positions in and recommends Apple, Microsoft, Nvidia, Taiwan Semiconductor Manufacturing, and Tencent. The Motley Fool recommends Alibaba Group. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Investors must treat these as distinct asset allocation tools rather than interchangeable international ETFs, as their risk-return profiles serve fundamentally different portfolio roles."
Comparing SPGM and SCHE is an apples-to-oranges exercise in portfolio construction, not a direct product competition. SPGM is essentially a 'Total World' proxy with a 62% U.S. tilt, effectively acting as a core equity holding. Conversely, SCHE is a satellite play on emerging market beta. The article glosses over the massive concentration risk in SCHE: with 16.3% in TSMC, it is essentially a leveraged bet on the semiconductor cycle and geopolitical stability in the Taiwan Strait. Investors shouldn't choose between these based on expense ratios; they should choose based on whether they need a global core (SPGM) or a high-volatility, non-correlated growth sleeve (SCHE).
If the U.S. enters a prolonged period of stagnant growth, the 'core' diversification of SPGM will underperform, making the concentrated emerging market exposure of SCHE the only source of alpha for a portfolio.
"N/A"
[Unavailable]
"SCHE's 16% single-stock concentration in TSMC plus 31% China exposure creates tail risk that the article dismisses as merely 'higher drawdown,' when it's actually a geopolitical binary that could impair the fund for years."
This article frames a false choice between 'emerging markets tilt' and 'global core holding,' but obscures a critical structural problem: SCHE's 16% TSMC concentration and 31% China exposure creates idiosyncratic risk that 2 basis points of fee savings doesn't compensate for. SPGM's 62% U.S. weighting means it's not really 'global diversification'—it's S&P 500 with a 38% satellite. The article's 5-year performance comparison (SPGM +77.5% vs SCHE +37.3%) is presented as SPGM superiority, but ignores that this period captured the U.S. mega-cap AI rally and Chinese policy headwinds. Neither fund is what it claims to be.
If you believe emerging markets will outperform developed markets over the next decade—a reasonable macro thesis given valuations and growth rates—SCHE's concentration risk becomes a feature, not a bug, and SPGM's U.S. tilt becomes the real drag.
"SPGM’s lower cost and breadth do not fully offset its US/tech concentration and smaller liquidity, which could hurt in regime shifts toward EM leadership or during liquidity stress."
SPGM appears attractive as a core international sleeve: broader global exposure, cheaper cost, and a smoother five-year track record versus SCHE, plus a modest drawdown. The article glosses over structural risks: SPGM’s roughly 62% U.S. weighting and heavy tech tilt makes it a U.S.-growth proxy, vulnerable to policy shifts, rate moves, or a dollar rally that can hurt non-U.S. peers; EM cycles could still outperform if growth re-accelerates, meaning SCHE’s EM tilt may shine in the next regime. SPGM’s relatively small $1.6B AUM also invites higher tracking error and liquidity risk in stress periods. Tax and distribution profiles deserve consideration too.
If the global cycle broadens and EMs lead—think China policy reforms and a commodity upswing—SCHE could outperform SPGM as the EM lever turns.
"The debate ignores that SCHE functions as an unhedged currency bet, while SPGM provides a structural hedge against dollar weakness."
Claude is right to highlight the mislabeling, but everyone is ignoring the currency risk. SPGM’s 62% U.S. tilt acts as a structural hedge against a weakening dollar, whereas SCHE’s high EM exposure leaves investors naked to currency volatility. If the Federal Reserve pivots to a weaker dollar regime, SCHE’s underlying assets might gain, but the FX translation could erode those returns. Investors aren't just buying equities; they are taking a massive, unhedged bet on the DXY index.
[Unavailable]
"SPGM's U.S. tilt amplifies dollar strength risk, not hedges it; SCHE benefits from dollar weakness via FX translation."
Gemini's DXY hedge argument is elegant but inverted. SPGM's 62% U.S. weighting isn't a dollar hedge—it's dollar exposure. If DXY weakens, U.S. equities typically rally (earnings boost), but foreign holdings get FX headwinds. SCHE's EM tilt actually benefits from dollar weakness via currency translation. The real risk: both funds are correlated to Fed policy, not inversely hedged.
"FX overlays and hedging costs are the real swing factor; SPGM is not a dollar hedge, and SCHE's EM gains depend on FX management as much as EM beta."
Claude's currency critique misses a practical lever: FX overlays, not geographic tilt, drive realized returns. Saying SPGM isn’t a 'dollar hedge' overlooks that a 62% U.S. weight still interacts with non-U.S. earnings and hedging costs; in a volatile regime, FX translation can swamp modest fee savings. Conversely, SCHE’s EM exposure isn’t a free tailwind—local policy and liquidity shocks can invert currency gains. The decision should hinge on how you plan to manage FX, not just beta exposures.
The panel agrees that SPGM and SCHE serve different purposes in a portfolio and should not be compared based on expense ratios alone. They highlight significant risks in both funds, including concentration risk in SCHE and currency risk in SPGM.
Potential for SCHE to shine in a new growth regime if EM cycles outperform
Concentration risk in SCHE (16.3% in TSMC) and currency risk in SPGM (62% U.S. tilt)